KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Cash from Financing Activities (2016 - 2026)

Boston Scientific's Cash from Financing Activities history spans 18 years, with the latest figure at -$260.0 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 211.59% to -$260.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$888.0 million, a 285.77% decrease, with the full-year FY2025 number at -$395.0 million, down 121.78% from a year prior.
  • Cash from Financing Activities hit -$260.0 million in Q1 2026 for Boston Scientific, down from -$184.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for BSX hit a ceiling of $1.6 billion in Q1 2024 and a floor of -$344.0 million in Q2 2022.
  • Historically, Cash from Financing Activities has averaged $36.2 million across 5 years, with a median of $1.0 million in 2022.
  • Biggest five-year swings in Cash from Financing Activities: crashed 17300.0% in 2022 and later surged 2373.91% in 2024.
  • Tracing BSX's Cash from Financing Activities over 5 years: stood at $1.0 million in 2022, then skyrocketed by 1400.0% to $15.0 million in 2023, then soared by 1326.67% to $214.0 million in 2024, then crashed by 185.98% to -$184.0 million in 2025, then plummeted by 41.3% to -$260.0 million in 2026.
  • Business Quant data shows Cash from Financing Activities for BSX at -$260.0 million in Q1 2026, -$184.0 million in Q4 2025, and -$104.0 million in Q3 2025.